apomorphine hydrochloride hemihydrate - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe AUST R: 129948 Active ingredients: apomorphine hydrochloride hemihydrate Dosage form: Injection, solution Sponsor: Stada Pharmaceuticals Australia Pty Ltd Phone: 1800 791 660	Deletion from market: 01 Oct 2026	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: An alternative presentation is available - MOVAPO POD apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for injection cartridge (ARTG 423350). Patients are advised to consult their healthcare professional to discuss alternative treatment options.

Product details

Supply Impact Dates

Further Details

MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe
AUST R: 129948
Active ingredients:
apomorphine hydrochloride hemihydrate

Dosage form:
Injection, solution

Sponsor:
Stada Pharmaceuticals Australia Pty Ltd

Phone:
1800 791 660

Deletion from market:
01 Oct 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available - MOVAPO POD apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for injection cartridge (ARTG 423350). Patients are advised to consult their healthcare professional to discuss alternative treatment options.